Danielle A. Cunningham, MD

#RadOnc Physician @KURadonc ⬅️ @MayoClinic RadOnc Residency ⬅️ @UMKCMedSchool ⬅️ #KCMO | #MedEd Illustrator | DM to collaborate

[Danielle A. Cunningham, MD @CunninghamOnc]

The Revised International Prognostic Index (R-IPI) DLBCL uses Age, ECOG performance status, LDH, Stage 3-4, and >1 extranodal sites to provide prognostic info
#hemonc #medonc #radonc #roedu #lymphoma #DLBCL

[PDBrown @PDBrownOnc]

Physicians & other overachievers always thinking about next task, not living in moment, WAKE UP or you will miss life

[Ronald Chen @RonaldChenMD]

I recommend standard of care radiation treatment, recommended by NCCN guidelines. @UHC @evicorehc denies preauth. I call for P2P and next available slot is one week away! Progressive cancer cannot wait. I escalate request and get no call back. #fixpriorauth @RogerMarshallMD

[Danielle A. Cunningham, MD @CunninghamOnc]

@PDBrownOnc @SimonLo21054188 @KURadonc @RonaldChenMD Those are beautiful! I did not make them, but would love to pick up a set!

[Krishan Jethwa @KrishanJethwa]

@PDBrownOnc dropping pearls of wisdom and insight!

A classic Paul Brown teaching for residents that has been ingrained.

“The greatest impacts we can make in our profession are with the patients sitting in front of us.” 🙏🏽🙏🏽🙏🏽

[Anna (Annie) LaVigne, MD @AnnaLaVigneMD]

Honored to have “Past Paste” selected for the September issue’s cover @IJROBP @sueyom @jenniferbellon2, thank you! Grateful for continued support of the #HealthHumanities @hopkinskimmel by @JHMRadOnc @ANViswanathanMD ☢️🎨✍️

[Ronald Chen @RonaldChenMD]

Congrats to Dr Akhavan! First R01 for junior faculty physician scientist @KURadonc @KUMedCenter Radiation oncologist doing cutting edge CAR T research. #wearemovingup

[PDBrown @PDBrownOnc]

Randomized Trial Vestibular Schwannoma
-No diff outcomes hearing, QOL, equilibrium between SRS or observe arm https://t.co/pr8ahdGRb0

[University Of Kansas Radiation Oncology @KURadonc]

Congratulations Dr. John Einck on being awarded the distinction of ASTRO Fellow (FASTRO)! ASTRO fellows are recognized for their commendable and sustained service to the field of Oncology and is earned by only a small percentage of the nearly 10,000 society members.

[PDBrown @PDBrownOnc]

Practice Changing Trial BRAF & MEK inhib newly diagnosed Papillary Craniopharyngiomas
· 94% response rate, vast majority durable
· Future less aggressive surgery
· ?? adjuvant vs salvage RT https://t.co/5aemSRGCQr

[ACROresident @ACROresident]

🎉 #radonc PGY-2 Twitter Orientation Week 🎉
ACRO has even more great resources!

♠️♥️♣️♦️ACRODecks by @QatKhanMD are a great intro for 🧠 & 🫁 services with more decks to come
https://t.co/uxPcYwqXrK

Also check out our Educational Videos 🎥 for 🔥 #radonc topics

[James Randall @JamesRandallMD1]

Good luck to all RO residents taking boards tomorrow, you got this 👍🏻 many thanks to all the educators who created wonderful tools for review @RadOncQuestions @CunninghamOnc @ARRO_org @roecsg

[Shane Stecklein, MD, PhD @shanestecklein]

Privileged to be part of this work from @SWOG led by @reshmajagsi and @KalinskyKevin. 2° analysis of RxPONDER: ⬇️ LRR in biologically favorable low-burden pN+ HR+/HER2- #breastcancer patients even without regional nodal #radiotherapy. Enroll on TAILOR RT! https://t.co/yqxUfrr9wD

[PDBrown @PDBrownOnc]

Kudos to Dr. Wijnenga @MartinvdenBent & colleagues for this informative study
This work supports CNS5GBM classification

- No diff OS isolated TERTp mutation
compared to cases with additional EGFR amplification and/or 7+/10-

[Anna M Brown, MD, MPhil (she/her) @jaguaranna27]

Had a wonderful *pregame* discussion tonight. Yay! Many thanks to @AnnaLaVigneMD, @CunninghamOnc, & Will Sperduto for taking time to brainstorm excellent #HealthHumanities ideas 💡

Thanks to @SprakerMDPhD & @ParikhSimul too 😊 TAP co-hosts

So excited for the full episode!!🥰🎨

[Mayo Clinic Radiation Oncology @MayoRadOnc]

Tonight, we celebrate our ⭐️outstanding⭐️ graduating 🎓residents @LindsayMorrisMD @CunninghamOnc @HunterGits. We are so so proud of all that you have done and all the patients you will help in the years to come! ❤️ Thank you for all you do!

[Krishan Jethwa @KrishanJethwa]

Congratulations to our graduates! So proud of the brilliant, talented, and compassionate physicians you have become! It was a privilege being a part of your journey! Cheers to @CunninghamOnc @HunterGits @LindsayMorrisMD @MayoRadOnc 🎉🎓

[Allison Garda @allisongardaMD]

I met @LindsayMorrisMD @HunterGits @CunninghamOnc when they were rotating med students and I was a brand new PGY2. Proud to have been co-residents -> APD for this class of outstanding physicians and people. Congrats & can’t wait to see what you all accomplish in the future!! 🎉

[PDBrown @PDBrownOnc]

Newly diagnosed GBM 12 cycles vs 6 cycles Temozolomide, is more better?
The answer is NO https://t.co/4M7S7ftY7N

[Vinai Gondi @vinaigondi]

@PDBrownOnc With compelling evidence supporting either HA-WBRT+memantine or SRS for small cell brain mets, we have reached equipoise in our field.  Our patients need our community to complete accrual to NRG CC009, SRS vs. HA-WBRT+memantine for small cell brain mets.

[JNCI @JNCI_Now]

In this JNCI CS report, AYA cancer survivors face physical and psychological sequelae decades after treatment completion, with common anxiety and depressive disorders. Preventive strategies are needed.
Read more here: https://t.co/SVnCwi4Wrj